E. Ohman J or Asset Management AB Increases Position in Astrana Health, Inc. (NASDAQ:ASTH)

E. Ohman J or Asset Management AB raised its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) by 85.8% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 61,300 shares of the company's stock after buying an additional 28,300 shares during the period. E. Ohman J or Asset Management AB owned about 0.12% of Astrana Health worth $1,901,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of ASTH. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Astrana Health during the 4th quarter valued at about $40,000. Quarry LP grew its position in shares of Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after acquiring an additional 471 shares during the period. KBC Group NV grew its position in shares of Astrana Health by 108.4% during the 4th quarter. KBC Group NV now owns 2,530 shares of the company's stock valued at $80,000 after acquiring an additional 1,316 shares during the period. US Bancorp DE grew its position in shares of Astrana Health by 3,880.0% during the 4th quarter. US Bancorp DE now owns 4,776 shares of the company's stock valued at $151,000 after acquiring an additional 4,656 shares during the period. Finally, PharVision Advisers LLC acquired a new stake in shares of Astrana Health during the 4th quarter valued at about $211,000. Hedge funds and other institutional investors own 52.77% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. Stifel Nicolaus dropped their target price on Astrana Health from $70.00 to $56.00 and set a "buy" rating on the stock in a research report on Thursday, February 20th. Truist Financial lowered their price objective on Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a report on Tuesday, March 18th. Barclays began coverage on Astrana Health in a report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 price objective on the stock. Bank of America lowered their price objective on Astrana Health from $55.00 to $49.00 and set a "buy" rating on the stock in a report on Tuesday, March 4th. Finally, Robert W. Baird lowered their price objective on Astrana Health from $86.00 to $50.00 and set an "outperform" rating on the stock in a report on Monday, March 3rd. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, Astrana Health has a consensus rating of "Moderate Buy" and an average price target of $53.29.

Astrana Health Trading Up 4.9%

ASTH traded up $1.25 during trading hours on Tuesday, reaching $26.53. The company's stock had a trading volume of 206,666 shares, compared to its average volume of 291,658. Astrana Health, Inc. has a fifty-two week low of $23.12 and a fifty-two week high of $63.20. The stock has a market cap of $1.49 billion, a PE ratio of 20.41, a P/E/G ratio of 1.37 and a beta of 0.85. The business's 50-day moving average is $28.95 and its 200-day moving average is $32.66. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $620.39 million during the quarter, compared to analyst estimates of $628.11 million. During the same quarter in the prior year, the company posted $0.31 earnings per share. The company's revenue was up 53.4% on a year-over-year basis. As a group, equities research analysts predict that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.